-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UlXdOOYO70ZTw9psnGiL5tbV/y91eSFEH/GzjOWXToP1imr78DPE2ml/eJtlBfD/ moRga/gdZiCpnBvvHfKqWg== 0000950005-97-000117.txt : 19970221 0000950005-97-000117.hdr.sgml : 19970221 ACCESSION NUMBER: 0000950005-97-000117 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970210 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-43408 FILM NUMBER: 97522651 BUSINESS ADDRESS: STREET 1: 901 MARINERS ISLAND BLVD STREET 2: SUITE 315 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 4153583456 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MOORE THOMAS E CENTRAL INDEX KEY: 0000903551 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O SCICLONE PHARMACEUTICALS INC STREET 2: 901 MARINERS ISLAND BLVD SUITE 315 CITY: SAN MATEO STATE: CA ZIP: 94404 SC 13G 1 FORM SC 13G ----------------------------------------- OMB Number: 3235-0145 Expires: October 31, 1994 Estimated average burden hours per response........................14.90 ----------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) SCICLONE PHARMACEUTICALS, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 80862K 10 4 -------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [ ]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 pages.
- --------------------------------------- -------------------------------------- CUSIP NO. 80862 10 4 13G Page 2 of 5 Pages ---------- - --------------------------------------- -------------------------------------- - ----------- --------------------------------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S. S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON THOMAS E. MOORE ###-##-#### - ----------- --------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* NOT APPLICABLE (a) [ ] (b) [ ] - ----------- --------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY - ----------- --------------------------------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - ----------- --------------------------------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 3,317,381 (AS OF DECEMBER 31, 1996) ---------- ------------------------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY NOT APPLICABLE ---------- ------------------------------------------------------------------------------- BY EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 3,317,381 (AS OF DECEMBER 31, 1996) ---------- ------------------------------------------------------------------------------- WITH 8 SHARED DISPOSITIVE POWER NOT APPLICABLE - -------------------------- ---------- ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,317,381 (AS OF DECEMBER 31, 1996) - ----------- --------------------------------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ----------- --------------------------------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 18.84% (AS OF DECEMBER 31, 1996) - ----------- --------------------------------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON * IN - ----------- --------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILING OUT!
Page 2 of 5 pages Schedule 13G Thomas E. Moore (cont.) Item 1. (a) Name of Issuer: SciClone Pharmaceuticals, Inc. (b) Address of Issuer's Principal Executive Offices: 901 Mariner's Island Boulevard, Suite 315, San Mateo, CA 94404 Item 2. (a) Name of Person Filing: Thomas E. Moore (b) Address of Principal Business Officer or, if none, Residence: 26201 Dori Lane Los Altos Hills, CA 94022 (c) Citizenship: United States (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 80862K 10 4 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b). . . Not applicable. Item 4. Ownership (a) Amount Beneficially Owned: 3,317,381 Common Stock, as of December 31, 1996 (b) Percent of Class: 18.84%, as of December 31, 1996 (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 3,317,381 (ii) shared power to vote or to direct the vote: -0- (iii) sole power to dispose or to direct the disposition of: 3,317,381 Page 3 of 5 pages. Schedule 13G Thomas E. Moore (cont.) (iv) shares power to dispose or to direct the disposition of: -0- Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the Class of securities, check the following: [ ] Item 6. Ownership of More than Five Percent of Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of the Group Not applicable. Item 10. Certification Not applicable. Page 4 of 5 pages. Schedule 13G Thomas E. Moore (cont.) SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 10, 1997 /s/ ----------------------------- THOMAS E. MOORE Page 5 of 5 pages. -----END PRIVACY-ENHANCED MESSAGE-----